[go: up one dir, main page]

UY28909A1 - ESTRADIOL PRODUCTS - Google Patents

ESTRADIOL PRODUCTS

Info

Publication number
UY28909A1
UY28909A1 UY28909A UY28909A UY28909A1 UY 28909 A1 UY28909 A1 UY 28909A1 UY 28909 A UY28909 A UY 28909A UY 28909 A UY28909 A UY 28909A UY 28909 A1 UY28909 A1 UY 28909A1
Authority
UY
Uruguay
Prior art keywords
estradiol
products
estradiol products
prodiges
steroid
Prior art date
Application number
UY28909A
Other languages
Spanish (es)
Inventor
Alexander Hillisch
Sven Ring
Ralf Wyrwa
Peter Droescher
Walter Elger
Gudrun Reddersen
Birgitt Schneider
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34969196&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY28909(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Ag filed Critical Schering Ag
Publication of UY28909A1 publication Critical patent/UY28909A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Prodrogas de estradiol de la fórmula general (I), donde el grupo Z está unido al esteroide, un procedimiento para su preparación, composiciones farmacéuticas que contienen estos compuestos y su uso para preparar medicamentos con efecto estrógeno.Prodiges of estradiol of the general formula (I), where the group Z is attached to the steroid, a process for its preparation, pharmaceutical compositions containing these compounds and their use for preparing drugs with estrogen effect.

UY28909A 2004-05-21 2005-05-19 ESTRADIOL PRODUCTS UY28909A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004025966A DE102004025966A1 (en) 2004-05-21 2004-05-21 Estradiol prodrugs

Publications (1)

Publication Number Publication Date
UY28909A1 true UY28909A1 (en) 2005-12-30

Family

ID=34969196

Family Applications (1)

Application Number Title Priority Date Filing Date
UY28909A UY28909A1 (en) 2004-05-21 2005-05-19 ESTRADIOL PRODUCTS

Country Status (11)

Country Link
EP (1) EP1747230A1 (en)
JP (1) JP2007538025A (en)
AR (1) AR050335A1 (en)
DE (1) DE102004025966A1 (en)
GT (1) GT200500121A (en)
PA (1) PA8633701A1 (en)
PE (1) PE20060359A1 (en)
SV (1) SV2006002121A (en)
TW (1) TW200613315A (en)
UY (1) UY28909A1 (en)
WO (1) WO2005113574A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10027887A1 (en) 2000-05-31 2001-12-13 Jenapharm Gmbh Compounds with a sulfonamide group and pharmaceutical compositions containing these compounds
US7534780B2 (en) 2004-05-21 2009-05-19 Bayer Schering Pharma Aktiengesellschaft Estradiol prodrugs
DE102004025985A1 (en) * 2004-05-21 2005-12-15 Schering Ag Estriol and estetrol prodrugs
DE102005057224A1 (en) * 2005-11-29 2007-05-31 Bayer Schering Pharma Ag New 9-alpha substituted estratriene derivatives esterified with a sulfamoylphenyl-substituted acid residue, are prodrugs useful as carboanhydrase inhibitors for treating estrogen deficiency disorders
DE102005057225A1 (en) * 2005-11-29 2007-05-31 Bayer Schering Pharma Ag New 8-beta-substituted estratriene derivatives esterified with a sulfamoylphenyl-substituted acid residue, are prodrugs useful as carboanhydrase inhibitors for treating estrogen deficiency disorders
DE102005057408A1 (en) * 2005-11-30 2007-05-31 Bayer Schering Pharma Ag New sulfamoylsulfonate prodrugs e.g. useful for protecting red blood cells from attack by parasites or for hormone replacement therapy, female fertility control or treating hormone-associated diseases
RU2667942C2 (en) * 2013-07-11 2018-09-27 Эвестра, Инк. Prodrug forming compounds
CN115368427B (en) * 2022-08-17 2024-02-13 南宁师范大学 Estradiol selenocyanate compounds and their preparation methods and applications

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1238739A (en) * 1958-08-04 1960-08-19 Chimiotherapie Lab Franc Process for the preparation of water-soluble testosterone derivatives
FR8290M (en) * 1968-12-31 1970-11-09 Rech Chimiques Et Ind Mar Lab
US5001234A (en) * 1987-04-16 1991-03-19 The Upjohn Company Cyclic hydrocarbons with an aminoalkyl sidechain
US5571933A (en) * 1994-11-17 1996-11-05 Duquesne University Of The Holy Ghost Derivatives of estra 1,3,5(10)triene-17-one, 3-amino compounds and their use
DE19712488A1 (en) * 1997-03-25 1998-10-01 Knoell Hans Forschung Ev Steroid sulfamates, processes for their preparation and use thereof
AU2001248849A1 (en) * 2000-04-24 2001-11-07 Kyowa Hakko Kogyo Co. Ltd. Estra-1,3,5(10)-triene derivatives
DE10027887A1 (en) * 2000-05-31 2001-12-13 Jenapharm Gmbh Compounds with a sulfonamide group and pharmaceutical compositions containing these compounds
GB0015876D0 (en) * 2000-06-28 2000-08-23 Novartis Ag Organic compounds
GB0316290D0 (en) * 2003-07-11 2003-08-13 Glaxo Group Ltd Novel compounds
TWI331154B (en) * 2003-11-12 2010-10-01 Solvay Pharm Gmbh Novel 17-hydroxysteroid dehydrogenase type i inhibitors
DE102004025985A1 (en) * 2004-05-21 2005-12-15 Schering Ag Estriol and estetrol prodrugs

Also Published As

Publication number Publication date
PA8633701A1 (en) 2006-07-03
AR050335A1 (en) 2006-10-18
TW200613315A (en) 2006-05-01
DE102004025966A1 (en) 2005-12-15
PE20060359A1 (en) 2006-05-25
SV2006002121A (en) 2006-02-15
JP2007538025A (en) 2007-12-27
WO2005113574A1 (en) 2005-12-01
EP1747230A1 (en) 2007-01-31
GT200500121A (en) 2006-01-30

Similar Documents

Publication Publication Date Title
UY30824A1 (en) NEW DERIVATIVES OF IDAZOLIL ESTER OR AMIDA, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, PREPARATION PROCESSES AND APPLICATIONS.
UY30711A1 (en) NEW DERIVATIVES OF 1,4-BENZOTIEPINA-1, 1-CIOXIDE, METHOD FOR PREPARATION, PHARMACEUTICAL PRODUCTS THAT INCLUDE THESE COMPOUNDS AND THEIR USE.-
ECSP066667A (en) SPIROCICLIC CYCLHEXAN DERIVATIVES
SV2002000249A (en) DERIVATIVES OF TIAZOLILAMIDA REF, LEA 34082-SV
UY29002A1 (en) NEW HIDANTOINE DERIVATIVES, PARASU PREPARATION PROCESSES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE IN THERAPY
ECSP055671A (en) NEW ESPIROCONDENSED QUINAZOLINONES AND ITS USE AS PHOSPHODESTERESA INHIBITORS
ECSP099620A (en) SPIROCICLIC CYCLHEXAN DERIVATIVES
AR025052A1 (en) DERIVATIVES OF 2-DIALQUILAMINOALQUILBIFENILO SUBSTITUTED, PROCEDURE FOR PREPARATION, MEDICATIONS CONTAINING THESE COMPOUNDS AND THE USE OF THESE COMPOUNDS FOR THE PREPARATION OF MEDICINES.
CU20110185A7 (en) NEW DERIVATIVES OF COMPOUNDS OF [3,2-C] STEROID PIRAZOL WITH GLUCOCORTICOID ACTIVITY
UY28909A1 (en) ESTRADIOL PRODUCTS
BRPI0507435A (en) piperidinylcarbonylpyrrolidines compounds, processes for their preparation, pharmaceutical composition and use as melanocortin agonists
UY30356A1 (en) DERIVATIVES OF 3-HALO-N- (2. (4-FLUOROPHENYL) -4-OXOBUTIL) -N-METIL-5- (TRIFLUOROMETIL) BENZAMIDE AND COMPOSITIONS OF THE SAME.
UY28910A1 (en) ESTRIOL AND ESTETROL PRODUCTS
UY29003A1 (en) NEW HIDANTOINE DERIVATIVES, PROCESSES FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THEIR USE IN THERAPY
UY28911A1 (en) STEROID PROPHARMS WITH ANDROGENIC ACTION
UY27133A1 (en) 11BETA-HALOGENESTEROIDS, ITS OBTAINING AND USE FOR THE PREPARATION OF MEDICINES AND PHARMACEUTICAL PREPARATIONS CONTAINING 11 BETA-HALOGENESTEROIDS
ECSP088481A (en) DRUGS OF ER-BETA-SELECTIVE SUBSTANCES, PROCESSES FOR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THESE PRODUCTS
CR7672A (en) MICROBIOLOGICAL METHOD FOR THE PRODUCTION OF 11- ALFA- HYDROXIESTEROIDS 7- ALFA SUBSTITUTED
UA93864C2 (en) Naphthalene derivatives, process for the preparation thereof and pharmaceutical compositions containing same
UY28846A1 (en) D-HOMO-17-CHLORINE-16 (17) ENO STEROIDS
ECSP066973A (en) D-HOMO-17-CHLORINE-16 (17) ENO STEROIDS
CO6470855A2 (en) 17 BETA-RENT-17ALFA-OXI-ESTTRATIENOS
CL2009001370A1 (en) Crystalline forms of (r, s) -, (r) - and (s) -dopc; Preparation process; pharmaceutical composition; and its use to prepare medicines.
ECSP088482A (en) DRUGS OF ER-BETA-SELECTIVE SUBSTANCES, PROCESSES FOR THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS
BRPI0518620A2 (en) compounds, pharmaceutical composition, method of preparing a composition, and use of a compound

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20160518